xbox高清视频线,国产精品偷伦视频免费观看了,中文字幕在线播放,亚瑟 中文字幕

關鍵詞:
  首頁 > 美迪醫訊 > Carbapenem antimicrobial drugs Report  

Carbapenem antimicrobial drugs Report

【?2008-07-21 發布?】 美迪醫訊
美迪網領先的醫療器械電子商務平臺

Carbapenem antimicrobial drugs Report

Research Report on Chinese Carbapenem antimicrobial drugs Market
Research Report on Chinese Carbapenem antimicrobial drugs Market
Price:  US$1,900
Contact: Mr.Humphrey  
Tel.: 86-10-58110925            Fax:  86-10-68588305
E-mail: hhuang@medicexchange.com                    
 
 
The peport presents China's market status and development trend of Carbapenems,a class of beta-lactam antibiotics with broad antibacterial spectrum and strong antibacterial action。The report describes the status and development trend about Research & Development and sales of Carbapenems within global market,the China's current market scale and growth trend of Carbapenems in the next 5 years,comparison of domestic prodcut's market share and import product's。 At last the report summarizes the information of international Research & Development for new Carbapenems,the status of application and approval for Carbapenems reviewed by SFDA。
 
   The data presented in this report can reflect the real market status in China,the China's market scale of Carbapenems grew from 230 million in 2000 to 680 million in 2005。
 
 
Table of Contents
 
Table of Contents
Abstract…………………………………………………………………………………1
Overview of products    3
1 General situation of international market of carbapenem
 antibiotics……………………………………………………………………………4
2 Carbapenem drugs market in China  6
  2.1 National market scale and growth trend from 2000 to 2005……6
  2.2 Shares and variation trend of national carbapenem drugs from
 2000 to 2005…………………………………………………………………………9
  2.3 Sale volume and growth trend of Imipenem/Cilastatinfrom 2000
 to 2005………………………………………………………………………………10
  2.4 Sale volume and growth trend of Meropenem from 2000 to
 2005……………………………………………………………………………………11
  2.5 Sale volume and growth trend of Panipenem/Betamipron from
 2000 to 2005…………………………………………………………………………11
  2.6 Sales Status of Import and Domestic Carbapenem Drugs…………12
  2.7 Evaluation on demand volume of carbapenem Bulk Drugs in the
 next 5 years…………………………………………………………………………13
3. Shares of brands…………………………………………………………………15
  3.1 Market share variation and advantage appraisal of the 5 brands
 from 2000 to 2005…………………………………………………………………15
    3.1.1 Market share variation of the 5 brands in recent 5 years…15
    3.1.2 Shares of brands in 2005……………………………………………17
    3.1.3 Sales Analysis on Different Brand Names of Meropenem from
 2000 to 2004…………………………………………………………………………17
  3.2 Market Shares of Different Brand Names in Sample Cities in
 2005……………………………………………………………………………………19
      “Tienam”……………………………………………………………………20
      “BeiNeng”……………………………………………………………………21
      “Mepem”………………………………………………………………………21
      “Carbenin”…………………………………………………………………23
      “Hisunpharm MeiTe”………………………………………………………23
  3.3 Market Shares of Different Brand Names in Major Cities in
 2005……………………………………………………………………………………24
      Beijing…………………………………………………………………………24
      Shanghai………………………………………………………………………25
      Guangzhou………………………………………………………………………26
4. Research and Development of new products………………………………27
  4.1 Domestic and imported products on Chinese market………………27
  4.2 Imitation and Application Status of Carbapenem Antimicrobial
 Drugs in China………………………………………………………………………29
    4.2.1 Types of products……………………………………………………29
    4.2.2 Application Enterprises……………………………………………31
  4.3 Background of other carbapenem drugs about to enter into
 Chinese market………………………………………………………………………38
      Biapenem………………………………………………………………………38
      Ertapenem……………………………………………………………………38
      Doripenem……………………………………………………………………39
  4.4 Penems products: comparison between Faropenem and
 carbapenems…………………………………………………………………………39
  4.5 Clinical evaluation of anti-severe infection drugs…………41
    4.5.1 Main characters of carbapenem antibiotics…………………41
    4.5.2 Clinical evaluation of carbapenems…………………………42
  4.6 Products in process of development in the world currently…45
Appendix 1 List of Enterprises Submited Applications for
 Carbapenems to SFDA………………………………………………………………47
Appendix 2 Retail Prices of  Different Carbapenems with Different
 Strengths……………………………………………………………………………59
 
Tables and Figures
 
Table 1 Launched Kinds of Carbapenems within the Global Market……4
Table 2 Sales Values of Carbapenems within the Global Market from
 2000 to 2004…………………………………………………………………………5
Table 3 Breeds in the Catalogue of Drugs for Basic National Medical
 Insurance………………………………………………………………………………6
Table 4 Market Scale of Carbapenems in China from 2000 to 2005……7
Table 5 Sales Scales of Three Carbapenems in 2005………………………9
Table 6 Sales Values of Imipenem/Cilastatin from 2000 to 2005……10
Table 7 Sales Values of Meropenem from 2000 to 2005……………………11
Table 8 Sales Values of Panipenem/Betamipron from 2001 to 2005……11
Table 9 Import Volumes of “TIENAM”(Imipenem/Cilastatin) from 2002
 to 2005………………………………………………………………………………12
Table 10 Import Volumes of “Mepem”(Meropenem) from 2002 to first
 half of 2005…………………………………………………………………………13
Table 11 Import Volumes of “Carbenin”(
本文關鍵字:
收藏本文到: Digg Live Bookmark Facebook 百度搜藏 新浪ViVi 365Key網摘 天極網摘 和訊網摘 POCO網摘 QQ書簽

  《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢

我要評論:《Carbapenem antimicrobial drugs Report》
匿名發表 我的名字: Email: 驗證碼: 點擊可刷新
 
    
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖
把美迪網放進收藏夾  把美迪醫療網介紹給我的朋友  給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303    美迪醫療網業務咨詢
互聯網藥品信息服務許可證:(滬)-經營性-2009-0003   中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8
 
公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號
營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081
消防排煙風機 華創商務網
美迪醫療網廣告業務聯系:021-51601230  產品咨詢業務聯系:021-51601230 傳真:021-56532303   美迪醫療網產品咨詢 本QQ僅咨詢廣告和會員業務,不咨詢產品和藥品等業務美迪醫療網推廣業務咨詢